326 related articles for article (PubMed ID: 25757854)
41. Extreme hyperferritinemia in the setting of acute myeloid leukaemia: a case report of hemophagocytic lymphohistiocytosis.
Denimal D; Ménégaut L; Rossi C; Duvillard L; Masson D
Biochem Med (Zagreb); 2016; 26(2):255-9. PubMed ID: 27346972
[TBL] [Abstract][Full Text] [Related]
42. Haemophagocytic lymphohistiocytosis: a case series from Mumbai.
Joshi R; Phatarpekar A; Currimbhoy Z; Desai M
Ann Trop Paediatr; 2011; 31(2):135-40. PubMed ID: 21575318
[TBL] [Abstract][Full Text] [Related]
43. The significance of pre-therapeutic F-18-FDG PET-CT in lymphoma-associated hemophagocytic lymphohistiocytosis when pathological evidence is unavailable.
Wang J; Wang D; Zhang Q; Duan L; Tian T; Zhang X; Li J; Qiu H
J Cancer Res Clin Oncol; 2016 Apr; 142(4):859-71. PubMed ID: 26666755
[TBL] [Abstract][Full Text] [Related]
44. Successful treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-94 protocol.
Lee JS; Kang JH; Lee GK; Park HJ
J Korean Med Sci; 2005 Apr; 20(2):209-14. PubMed ID: 15831988
[TBL] [Abstract][Full Text] [Related]
45. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.
Henter JI; Horne A; Aricó M; Egeler RM; Filipovich AH; Imashuku S; Ladisch S; McClain K; Webb D; Winiarski J; Janka G
Pediatr Blood Cancer; 2007 Feb; 48(2):124-31. PubMed ID: 16937360
[TBL] [Abstract][Full Text] [Related]
46. Profile of hemophagocytic lymphohistiocytosis; efficacy of intravenous immunoglobulin therapy.
Rajajee S; Ashok I; Manwani N; Rajkumar J; Gowrishankar K; Subbiah E
Indian J Pediatr; 2014 Dec; 81(12):1337-41. PubMed ID: 24806152
[TBL] [Abstract][Full Text] [Related]
47. Secondary hemophagocytic syndrome in adults: a case series of 18 patients in a single institution and a review of literature.
Shabbir M; Lucas J; Lazarchick J; Shirai K
Hematol Oncol; 2011 Jun; 29(2):100-6. PubMed ID: 20809477
[TBL] [Abstract][Full Text] [Related]
48. What's in a name? The heterogeneous clinical spectrum and prognostic factors in a cohort of adults with hemophagocytic lymphohistiocytosis.
Prokesch BC; Nagalla S; Ezzati F; Tujios SR; Dominguez A; Chen W; Kershaw C; Patel P; de la Flor C; Foster J; Martin AA; de la Morena MT; Wysocki CA
Transfus Apher Sci; 2018 Dec; 57(6):779-784. PubMed ID: 30327177
[TBL] [Abstract][Full Text] [Related]
49. Secondary hemophagocytic lymphohistiocytosis in pediatric patients: a single center experience and factors that influenced patient prognosis.
Oguz MM; Sahin G; Altinel Acoglu E; Polat E; Yucel H; Oztek Celebi FZ; Unsal H; Akcaboy M; Sari E; Senel S
Pediatr Hematol Oncol; 2019 Feb; 36(1):1-16. PubMed ID: 30821552
[TBL] [Abstract][Full Text] [Related]
50. Risk factors and prognosis of early death in secondary hemophagocytic lymphohistiocytosis.
Zhang Q; Zhu L; Zhou D; Li L; Xie W; Tan Y; Ye X
Ann Hematol; 2023 Sep; 102(9):2301-2308. PubMed ID: 37266671
[TBL] [Abstract][Full Text] [Related]
51. [Clinical analysis on 28 patients with hemophagocytic lymphohistiocytosis syndrome].
Shu MM; Zhu HF; Zhang T; Gao GX; Chen XQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):463-5. PubMed ID: 20416189
[TBL] [Abstract][Full Text] [Related]
52. [Retrospective analysis of 41 childhood hemophagocytic syndrome].
Guo X; Li Q; Zhou CY
Zhonghua Xue Ye Xue Za Zhi; 2007 Jul; 28(7):449-53. PubMed ID: 18072626
[TBL] [Abstract][Full Text] [Related]
53. Comparison between clinical features and prognosis of malignancy- and non-malignancy-associated pediatric hemophagocytic lymphohistiocytosis.
Pan H; Huo Y; Sun L
BMC Pediatr; 2019 Nov; 19(1):468. PubMed ID: 31783813
[TBL] [Abstract][Full Text] [Related]
54. [Clinical characteristics and prognosis of lymphoma-associated hemophagocytic syndrome].
Zhao AL; Li M; Li LF; Gan XA; Wang J; Li H; Shen K; Yang YF; Niu T
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(28):2173-2180. PubMed ID: 35872581
[No Abstract] [Full Text] [Related]
55. Neurological presentation of hemophagocytic lymphohistiocytosis.
Kamila ŻW; Teresa R; Patrycja MG; Andrzej S
Neurol Neurochir Pol; 2015; 49(5):329-31. PubMed ID: 26377985
[TBL] [Abstract][Full Text] [Related]
56. Ruxolitinib combined with doxorubicin, etoposide, and dexamethasone for the treatment of the lymphoma-associated hemophagocytic syndrome.
Zhou L; Liu Y; Wen Z; Yang S; Li M; Zhu Q; Qiu S; Gao Y; Wang H; Yuan Y; Zhang H; Chen C; Zeng W; Guan Z; Pan X
J Cancer Res Clin Oncol; 2020 Nov; 146(11):3063-3074. PubMed ID: 32617699
[TBL] [Abstract][Full Text] [Related]
57. Haemophagocytic lymphohistiocytosis that spontaneously resolved: a case of EBV.
Chahine Z; Jayakrishnan T; Samhouri Y; Fazal S
BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33184051
[TBL] [Abstract][Full Text] [Related]
58. Treatment outcomes and prognostic factors in adult patients with secondary hemophagocytic lymphohistiocytosis not associated with malignancy.
Yoon JH; Park SS; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Lee JW
Haematologica; 2019 Feb; 104(2):269-276. PubMed ID: 30213834
[TBL] [Abstract][Full Text] [Related]
59. Practice patterns and outcomes of hemophagocytic lymphohistiocytosis in adults: a 2-decade provincial retrospective review.
Croden J; Bilston L; Taparia M; Grossman J; Sun HL
Ann Hematol; 2022 Oct; 101(10):2297-2306. PubMed ID: 35978181
[TBL] [Abstract][Full Text] [Related]
60. [Clinical and genetic mutation characteristics of patients with primary hemophagocytic lymphohistiocytosis and their impact on prognosis].
Dou LR; Yu MZ; Shi L; Zhang J; Wu L; Wang JS; Wang Z
Zhonghua Yi Xue Za Zhi; 2024 Jun; 104(23):2160-2166. PubMed ID: 38871474
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
